As it occurs in the Wilms tumor, we also identified a splicing site mutation in CTR9. Interestingly, evidence indicates that CTR9 plays an import role in regulating the estrogen signaling pathway, which promotes estrogen receptor α (ERα) positive BC progression (Zeng and Xu, 2015). Here, ESR1 is linked to Nephroblastoma.